Published Date: 05 Jul 2024
Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors
Read Full NewsHigher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.
Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.
Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.
1.
Do I qualify for a cancer clinical trial?
2.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
3.
According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.
4.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
5.
Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.
1.
Patient-Centric Approaches in Oncology
2.
Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
5.
Cloud-Based Hematology Care Pathways: Integrating Digital Transformation in Blood Disorders Management
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation